MSCA Postdoctoral Fellowship with RCSI
RCSI University of Medicine and Health Sciences is seeking expressions of interest from enthusiastic and talented postdoctoral researchers who wish to apply for a Marie Skłodowska Curie Actions (MSCA) Postdoctoral Fellowship.
Funded by the European Commission under the Horizon Europe programme, MSCA Postdoctoral Fellowships are designed to enhance the creative and innovative potential of researchers through advanced training, international, interdisciplinary, and inter-sectoral mobility. Candidates must apply together with a supervisor based in an eligible host institution.
Types of fellowships
- European Fellowships: Open to researchers of any nationality moving to RCSI from abroad.
- Global Fellowships: Open to European nationals or long-term residents (>5 years in Europe) who wish to engage in research outside Europe before completing a final year at RCSI.
Who can apply?
Promising researchers of any nationality who:
- Are in possession of a PhD at the call deadline.
- Have a maximum of eight years' full-time equivalent research experience post-PhD*
- Have not lived or worked in Ireland (European Fellowship) or the country of the outgoing host organisation (Global Fellowship) for more than 12 months in the 36 months prior to the call deadline.
*years of experience outside research and career breaks will not count towards the above maximum, nor will years of experience in research in third countries, for nationals or long-term residents of EU Member States or Horizon Europe associated countries who wish to reintegrate to Europe.
What's covered?
A generous salary (living allowance and mobility allowance; MSCA Postdoctoral Fellows may also be eligible for family allowance and special needs allowance) as well as research, training, and networking costs.
Why RCSI?
Located in the heart of Dublin city, RCSI is an independent not-for-profit education and research institution, covering all areas of medicine and health sciences.
RCSI’s mission is to improve human health through translational research. We promote innovative research that leads to improved diagnostics, therapeutics, and devices; tackles important healthcare delivery issues; informs policy and clinical practice; and enhances the quality of education of healthcare professionals.
RCSI is committed to the United Nations’ Sustainable Development Goals. This reflects our commitment to supporting people of all ages to live healthy lives and our work to promote the concepts of well-being and positive health.
As an exclusively health sciences-focused education and research institution with strong links to acute hospitals, RCSI is uniquely placed to develop and enhance research for the benefit of patients and to improve human health. Our strategic research themes include:
- Biomaterials, Medical Devices and Pharmaceutical Sciences
- Cancer
- Neurological and Psychiatric Disorders
- Population Health and Health Services
- Surgical Science and Practice
- Vascular Biology and Cardiology
- Respiratory and Critical Care
RCSI can offer you a comprehensive research experience that paves the way for a pioneering life of leadership in healthcare research.
The RCSI Office of Research and Innovation can help you:
- Identify a suitable supervisor
- Draft a competitive proposal
- Align your proposal with EU and RCSI missions
- Design the most appropriate career development plan for you
RCSI has hosted >50 MSCA Fellows in the last nine years, and has an application success rate of 45%.
How to apply
You must meet the eligibility criteria described above and should possess a strong publication record (at least one important publication as first author). You will be expected to co-create the proposal idea with your RCSI-based MSCA Postdoctoral Fellowship supervisor.
Applications are encouraged from researchers with backgrounds in complementary disciplines (e.g. physics, engineering or social sciences) and an interest in pursuing health research.
If you are interested in applying, please provide the following via email to eufundingsupport@rcsi.ie no later than 1 June 2025.
- The name of the PI you are interested in working with (if known; a list of potential supervisors can be found below).
- A copy of your CV.
- A letter of intent that includes:
- Your current research interests.
- Your motivation for applying for an MSCA Postdoctoral Fellowship.
The following RCSI-based principal investigators (PIs) have expressed an interest in supporting enthusiastic and talented postdoctoral researchers who wish to apply for an MSCA Postdoctoral Fellowship.
PI | School/Department | Areas of research interest for MSCA PF supervision |
Oran Kennedy |
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine | Biomaterials, musculoskeletal medicine, bone, cartilage, osteocytes, osteoarthritis, synovitis, drug delivery |
Shane Browne |
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine | Injectable hydrogels, hyaluronic acid, wound repair, cell and therapeutic delivery, in vitro models, vascularisation |
Tom Hodgkinson |
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine | Osteochondral regeneration, cell engineering, synthetic biology, epigenetics, ageing, biomaterials, additive manufacturing, 3D printing, melt electrowriting |
Grace O'Malley |
School of Physiotherapy | Digital healthcare, AI in telemedicine |
Ali Hasnain |
School of Pharmacy and Biomolecular Sciences | Use of AI (conversational and GenAI) in healthcare. Digital health and artificial intelligence. Use of healthcare data and genomics and personalised medicine. |
Frank Moriarty |
School of Pharmacy and Biomolecular Sciences | Pharmacoepidemiology, appropriate prescribing and deprescribing, pharmaceutical policy, pharmacovigilance, management of chronic disease, primary care. |
Jennifer Dowling |
School of Pharmacy and Biomolecular Sciences | Immunometabolism, multiple sclerosis, brain metastasis |
Michelle Flood |
School of Pharmacy and Biomolecular Sciences | Patient and public involvement and engagement. Co-design in health services research. |
Roger Preston |
School of Pharmacy and Biomolecular Sciences | Blood coagulation, immunity, thrombosis. |
Sudipto Das | School of Pharmacy and Biomolecular Sciences | Epigenetics, personalised/precision medicine, cancer, gastrointestinal diseases, inflammation, genomics, AI/machine learning |
Aisling Walsh |
Public Health and Epidemiology | Maternal health services research, from pre-conception to postpartum and for women with chronic conditions and disability, as well as a focus on marginalised groups. |
Edward Gregg |
Population Health | Epidemiology and prevention of diabetes, chronic conditions, and multiple long-term conditions. Global health aspects of non-communicable diseases. Impact of lifestyle and related health services interventions. |
Alan Maddock |
Health Psychology | Mindfulness-based interventions for mental health and well-being outcomes. Mental health intervention research, including digital interventions. Supporting youth mental health. Supporting persons experiencing homelessness. |
Frank Doyle |
Health Psychology | Psychometrics tobacco/vaping, evidence synthesis (e.g. network meta-analysis), merging population health databases |
Maria Pertl | Health Psychology | Cancer survivorship, mental health, dementia and caregiving, down syndrome, lifestyle medicine |
Mary Clarke | Health Psychology | Early identification and prevention of risk for later mental illness, especially risk and prognostic factors in the perinatal and early childhood period. The impact of childhood trauma on mental health and wellbeing and trauma-informed education and policy. |
John-Paul Byrne |
Graduate School of Healthcare Management | Social determinants of healthcare work. Working conditions and well-being in health. Psychosocial work environments. Ethnographic and qualitative methods. |
Éidín Ní Shé |
Graduate School of Healthcare Management | Co-design healthcare,management, care of older people |
Niamh Humphries |
Graduate School of Healthcare Management | Health workforce research, health worker retention, health workers migration |
Ann Hopkins | Department of Surgery | JAM-A as a novel druggable target in various cancers. Companion blood biomarkers of oncological disease progression. Immunocompetent non-animal models to model cancer progression and treatment. |
Melanie Foecking | Department of Psychiatry | Schizophrenia, depression, biomarker, inflammation, synaptic transmission, nutritional psychiatry. |
Patrick Redmond | Department of General Practice | Early detection pathways, such as screening programmes and mobile health interventions. Leveraging digital health and AI for epidemiological studies, AI-driven support tools and NLP models. Implementation science, such as trialling cancer prevention strategies and translating research to policy. Primary care-based clinical trials of new diagnostics and interventions |
Caitriona Cahir | Data Science Centre, School of Population Health |
Epidemiology and population health. All areas are welcome. I work on research across chronic diseases (in particular cancer and older populations) and have done a lot of research around medication management and health outcomes, as well as investigating social determinants of health and other risk factors associated with population health outcomes. I use both quantitative and qualitative research methodologies. |
Kathleen Bennett | Data Science Centre, School of Population Health | Cancer epidemiology, chronic disease epidemiology and pharmacoepidemiology. Application of data analytics to healthcare. |
Marc Devocelle | Chemistry | Green peptide synthesis. Synthesis and modification of antimicrobial peptides, used as antibiotic candidates and/or antibiofilm coatings. |
Natalie McEvoy | Anaesthesia and Critical Care | Neurocritical care, organ donation, ARDS, quantitative and qualitative research methods. |